IQVIA Japan 2019 Pharma Market Insights – Market Continues Along a New Path

Date: Wednesday, April 3, 2019
Time: 12:00 - 14:00
Venue: Roppongi Hills Club, 51st Fl.
Speaker: Alan Thomas, Director, Thought Leadership, IQVIA Japan K.K.
Hosting Committees: 
Healthcare, Digital Health, 
​Medical Devices and Diagnostics, 
Pharmaceuticals, 
Regenerative Medicine and Bioscience
Member Fee: ¥5,500
Guest Fee: ¥​8,900
Meal: Plated Lunch 
Registration/Cancellation Deadline: Friday, March 29, 12:00 noon​

SIGN UP

Strategic opportunities including specialty and biologics, alongside investment in innovation and launch, underline Japan’s position as the second-largest pharma market for R&D-driven pharma companies. Continued pressure on healthcare spending, however, is impacting both government policy and pharma company strategy as a balance emerges to support patient access to newer, safer and more effective treatments. While companies that made the shift in strategy reap their rewards, those that did not are now re-assessing their position. 

At a ‘must’ event for the pharma industry, join us for a discussion of these and other issues impacting the Japan market today and in the years ahead with Alan Thomas,  Director, Thought Leadership at IQVIA Japan K.K.

John W. Carlson III, Chair
William Bishop, Yuko Kidoguchi, Takeo Morooka, Toshio Nagase, R. Byron Sigel, Mika Shirai, Vice Chairs
ACCJ Healthcare Committee

Eiji Sasahara, Chair
Eriko Asai, Marc Fuoti, Vice Chairs
ACCJ Digital Health Subcommittee 

William Bishop, Chair
Marie Kissel, Yasuhiko Amano, Jun Sekiguchi, Vice Chairs
ACCJ Medical Devices and Diagnostics Subcommittee

Takeo Morooka, Chair
ACCJ Pharmaceuticals Subcommittee

Yaju Hiromichi, Chair
Satoshi Tanaka, Vice Chair
ACCJ Regenerative Medicine and Bioscience Subcommittee

NOTE 1: This event is OFF THE RECORD.

NOTE 2: If you cancel after the stated deadline, the full meeting fee will be charged to your account. All guests must be accompanied by an ACCJ member. Sorry, no substitutions or walk-ins.

​NOTE 3: 500 yen of each participant's attendance fee will be deposited into the Healthcare Committee Fund.